Please use this identifier to cite or link to this item: http://dspace.mediu.edu.my:8181/xmlui/handle/10261/3299
Full metadata record
DC FieldValueLanguage
dc.creatorMañes, Santos-
dc.creatorMira, Emilia-
dc.creatorColomer, Ramón-
dc.creatorMontero, Sagrario-
dc.creatorReal, Luis M.-
dc.creatorGómez-Moutón, Concepción-
dc.creatorJiménez Baranda, Sonia-
dc.creatorGarzón, Alfredo-
dc.creatorLacalle, Rosa Ana-
dc.creatorHarshman, Keith-
dc.creatorRuíz, Agustín-
dc.creatorMartínez-Alonso, Carlos-
dc.date2008-03-25T11:36:00Z-
dc.date2008-03-25T11:36:00Z-
dc.date2003-11-
dc.date.accessioned2017-01-31T01:00:55Z-
dc.date.available2017-01-31T01:00:55Z-
dc.identifierThe Journal of Experimental Medicine, Volume 198, Number 9, November 3, 2003, pp. 1381–1389-
dc.identifier0022-1007-
dc.identifierhttp://hdl.handle.net/10261/3299-
dc.identifier10.1084/jem.20030580-
dc.identifier.urihttp://dspace.mediu.edu.my:8181/xmlui/handle/10261/3299-
dc.descriptionCopyright © by The Rockefeller University Press-
dc.descriptionChemokines are implicated in tumor pathogenesis, although it is unclear whether they affect human cancer progression positively or negatively. We found that activation of the chemokine receptor CCR5 regulates p53 transcriptional activity in breast cancer cells through pertussis toxin–, JAK2-, and p38 mitogen–activated protein kinase–dependent mechanisms. CCR5 blockade significantly enhanced proliferation of xenografts from tumor cells bearing wild-type p53, but did not affect proliferation of tumor xenografts bearing a p53 mutation. In parallel, data obtained in a primary breast cancer clinical series showed that disease-free survival was shorter in individuals bearing the CCR5 32 allele than in CCR5 wild-type patients, but only for those whose tumors expressed wild-type p53. These findings suggest that CCR5 activity influences human breast cancer progression in a p53-dependent manner.-
dc.descriptionPeer reviewed-
dc.format573259 bytes-
dc.formatapplication/pdf-
dc.languageeng-
dc.publisherRockefeller University Press-
dc.rightsopenAccess-
dc.subjectChemokine receptor-
dc.subjectBreast cancer-
dc.subjectp53-
dc.subjectCCR5 polymorphism-
dc.subjectp38-
dc.titleCCR5 expression influences the progression of human breast cancer in a p53-dependent manner-
dc.typeArtículo-
Appears in Collections:Digital Csic

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.